Active Pharmaceutical Ingredient (API) >>Trelagliptin succinate

Trelagliptin Succinate

Trelagliptin succinate is a long acting dipeptidyl peptidase-4 (DPP-4) inhibitor, that is being used for the treatment of type 2 diabetes.

Trelagliptin succinate is orally active DPP-4 inhibitor that produces clinically and statistically significant improvements in glycaemic control in patients with type 2 diabetes. Trelagliptin succinate has a long duration of action and is well tolerated effects studies to treat type 2 diabetes.

Trelagliptin succinate is white to off-white solid and soluble in Dimethyl sulfoxide, not in water.

CAS NO.: 1029877-94-8
SYR 111472 succinate; SYR 472
MF: C18H20FN5O2.C4H6O4
MW: 475.47

Notice: If the compound involved in patent protection, do not use for commercial purposes, and only for the purpose of analysis and research experiments. If it’s sold to countries which constitute patent infringement, All the risks corresponding are unrelated to our company.

Trelagliptin succinate

Stay connected with our social network